R&D/ Views & Analysis/ Views and analysis Casting aside CRISPR scissors and making a point with base editors mike.hammerton@pharmaphorum.com CRISPR, gene editing, immune cell therapy, Kymriah, Perkin Elmer, Yescarta 0 Comment Dr Jennifer Harbottle, senior scientist in the R&D Base Editing team of PerkinElmer’s Horizon Discovery business, looks at Share X Casting aside CRISPR scissors and making a point with base editors https://pharmaphorum.com/r-d/views-analysis-r-d/immune-cell-therapies-crispr-cas9-gene-editing/